Similar arrhythmicity in hypertrophic and fibrotic cardiac cultures caused by distinct substrate-specific mechanisms

Cardiovascular Research

Volumn 97, Issue 1, 2013, Pages 171-181

  Askar, Saïd F A ^a   Bingen, Brian O ^a   Schalij, Martin J ^a   Swildens, Jim ^a   Atsma, Douwe E ^a   Schutte, Cindy I ^a   De Vries, Antoine A F ^a   Zeppenfeld, Katja ^a   Ypey, Dirk L ^a   Pijnappels, Daniël A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Fibrosis; Hypertrophy; Substrate; Tachyarrhythmias

Indexed keywords

CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL CAV1.2; CARBENOXOLONE; CONNEXIN 43; NITRENDIPINE; POTASSIUM CHANNEL KV4.3; POTASSIUM CHANNEL KV7.1; SODIUM CHANNEL NAV1.5; UNCLASSIFIED DRUG; VERAPAMIL; VOLTAGE GATED POTASSIUM CHANNEL;

ANIMAL CELL; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CALCIUM CELL LEVEL; CELL PROLIFERATION; CONTROLLED STUDY; HEART ARRHYTHMIA; HEART CONDUCTION; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART REPOLARIZATION; HEART VENTRICLE; HEART VENTRICLE HYPERTROPHY; IN VITRO STUDY; MYOFIBROBLAST; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ACTION POTENTIALS; ANIMALS; ANIMALS, NEWBORN; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIAS, CARDIAC; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; CARDIOMEGALY; CELLS, CULTURED; COCULTURE TECHNIQUES; CONNEXIN 43; FIBROBLASTS; FIBROSIS; GAP JUNCTIONS; KINETICS; MYOCYTES, CARDIAC; PATCH-CLAMP TECHNIQUES; PHENYLEPHRINE; RATS; SHAL POTASSIUM CHANNELS; VOLTAGE-SENSITIVE DYE IMAGING;

EID: 84871760822     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvs290     Document Type: Article

References (38)

1. Haider AW, Larson MG, Benjamin EJ, Levy D. Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J Am Coll Cardiol 1998;32:1454-1459. (Pubitemid 28522409)
2. McLenachan JM. Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy. N Engl J Med 1987;317:787-792. (Pubitemid 17133358)
3. van der Burg AE, Bax JJ, Boersma E, Pauwels EK, van der Wall EE, Schalij MJ. Impact of viability, ischemia, scar tissue, and revascularization on outcome after aborted sudden death. Circulation 2003;108:1954-1959. (Pubitemid 37303911)
4. Kuck KH, Schaumann A, Eckardt L, Willems S, Ventura R, Delacretaz E et al. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease VTACH): a multicentre randomised controlled trial. Lancet 2010;375:31-40.
5. Zeppenfeld K, Stevenson WG. Ablation of ventricular tachycardia in patients with structural heart disease. Pacing Clin Electrophysiol 2008;31:358-374. (Pubitemid 351337530)
6. Borleffs CJ, van EL, Schotman M, Boersma E, Kies P, van der Burg AE et al. Recurrence of ventricular arrhythmias in ischaemic secondary prevention implantable cardiover-ter defibrillator recipients: long-term follow-up of the Leiden out-of-hospital cardiac arrest study (LOHCAT). Eur Heart J 2009;30:1621-1626.
7. Arshad A, Mandava A, Kamath G, Musat D. Sudden cardiac death and the role of medical therapy. Prog Cardiovasc Dis 2008;50:420-438. (Pubitemid 351649368)
8. Pijnappels DA, Schalij MJ, Ramkisoensing AA, van Tuyn J, de Vries AA, van der Laarse A et al. Forced alignment of mesenchymal stem cells undergoing cardiomyo-genic differentiation affects functional integration with cardiomyocyte cultures. Circ Res 2008;103:167-176.
9. Askar SF, Ramkisoensing AA, Schalij MJ, Bingen BO, Swildens J, van der Laarse A et al. Antiproliferative treatment of myofibroblasts prevents arrhythmias in vitro by limiting myofibroblast-induced depolarization. Cardiovasc Res 2011;90:295-304.
10. + channels: regulation of a transient outward current by protein kinase C. Am J Physiol Heart Circ Physiol 2008;294:1010-1017.
11. Askar SF, Bingen BO, Swildens J, Ypey DL, van der Laarse A, Atsma DE et al. Con-nexin43 silencing in myofibroblasts prevents arrhythmias in myocardial cultures: role of maximal diastolic potential. Cardiovasc Res 2012;93:434-444.
12. Kleber AG, Rudy Y. Basic mechanisms of cardiac impulse propagation and associated arrhythmias. Physiol Rev 2004;84:431-488. (Pubitemid 38365490)
13. Pogwizd SM, Hoyt RH, Saffitz JE, Corr PB, Cox JL, Cain ME. Reentrant and focal mechanisms underlying ventricular tachycardia in the human heart. Circulation 1992; 86:1872-1887.
14. de Bakker JM, van Capelle FJ, Janse MJ, Wilde AA, Coronel R, Becker AE et al. Reentry as a cause of ventricular tachycardia in patients with chronic ischemic heart disease: electrophysiologic and anatomic correlation. Circulation 1988;77:589-606. (Pubitemid 18073351)
15. Allessie MA, Bonke FI, Schopman FJ. Circus movement in rabbit atrial muscle as a mechanism of tachycardia. III. The 'leading circle' concept: a new model of circus movement in cardiac tissue without the involvement of an anatomical obstacle. Circ Res 1977;41:9-18. (Pubitemid 8132078)
16. Hou L, Deo M, Furspan P, Pandit SV, Mironov S, Auerbach DS et al. A major role for HERG in determining frequency of reentry in neonatal rat ventricular myocyte mono-layer. Circ Res 2010;107:1503-1511.
17. Lim ZY, Maskara B, Aguel F, Emokpae R Jr, Tung L. Spiral wave attachment to millimeter-sized obstacles. Circulation 2006;114:2113-2121. (Pubitemid 44747891)
18. Baker LC, London B, Choi BR, Koren G, Salama G. Enhanced dispersion of repolar-ization and refractoriness in transgenic mouse hearts promotes reentrant ventricular tachycardia. Circ Res 2000;86:396-407. (Pubitemid 30141758)
19. Chang MG, Zhang Y, Chang CY, Xu L, Emokpae R, Tung L et al. Spiral waves and reentry dynamics in an in vitro model of the healed infarct border zone. Circ Res 2009;105:1062-1071.
20. Weiss JN, Garfinkel A, Karagueuzian HS, Chen PS, Qu Z. Early afterdepolarizations and cardiac arrhythmias. Heart Rhythm 2010;7:1891-1899.
21. Sato D, Xie LH, Sovari AA, Tran DX, Morita N, Xie F et al. Synchronization of chaotic early afterdepolarizations in the genesis of cardiac arrhythmias. Proc Natl Acad Sci USA 2009;106:2983-2988.
22. Qin D, Zhang ZH, Caref EB, Boutjdir M, Jain P, El-Sherif N. Cellular and ionic basis of arrhythmias in postinfarction remodeled ventricular myocardium. Circ Res 1996;79:461-473. (Pubitemid 26276907)
23. Stengl M, Ramakers C, Donker DW, Nabar A, Rybin AV, Spatjens RL et al. Temporal patterns of electrical remodeling in canine ventricular hypertrophy: focus on IKs downregulation and blunted beta-adrenergic activation. Cardiovasc Res 2006;72:90-100. (Pubitemid 44429905)
24. Xie Y, Sato D, Garfinkel A, Qu Z, Weiss JN. So little source, so much sink: requirements for afterdepolarizations to propagate in tissue. Biophys J 2010;99:1408-1415.
25. Liu J, Laurita KR. The mechanism of pause-induced torsade de pointes in long QT syndrome. J Cardiovasc Electrophysiol 2005;16:981-987.
26. Spach MS, Dolber PC. Relating extracellular potentials and their derivatives to aniso-tropic propagation at a microscopic level in human cardiac muscle. Evidence for electrical uncoupling of side-to-side fiber connections with increasing age. Circ Res 1986; 58:356-371. (Pubitemid 16120759)
27. de Bakker JM, van Capelle FJ, Janse MJ, Tasseron S, Vermeulen JT, de JN et al. Slow conduction in the infarcted human heart. 'Zigzag' course of activation. Circulation 1993;88:915-926. (Pubitemid 23264006)
28. Vasquez C, Mohandas P, Louie KL, Benamer N, Bapat AC, Morley GE. Enhanced fibroblast-myocyte interactions in response to cardiac injury. Circ Res 2010;107:1011-1020.
29. Miragoli M, Salvarani N, Rohr S. Myofibroblasts induce ectopic activity in cardiac tissue. Circ Res 2007;101:755-758. (Pubitemid 350287189)
30. Miragoli M, Gaudesius G, Rohr S. Electrotonic modulation of cardiac impulse conduction by myofibroblasts. Circ Res 2006;98:801-810.
31. Zlochiver S, Munoz V, Vikstrom KL, Taffet SM, Berenfeld O, Jalife J. Electrotonic myofibroblast-to-myocyte coupling increases propensity to reentrant arrhythmias in two-dimensional cardiac monolayers. Biophys J 2008;95:4469-4480.
32. Pedrotty DM, Klinger RY, Kirkton RD, Bursac N. Cardiac fibroblast paracrine factors alter impulse conduction and ion channel expression of neonatal rat cardiomyocytes. Cardiovasc Res 2009;83:688-697.
33. Danik SB, Liu F, Zhang J, Suk HJ, Morley GE, Fishman GI et al. Modulation of cardiac gap junction expression and arrhythmic susceptibility. Circ Res 2004;95:1035-1041. (Pubitemid 39532334)
34. Peters NS, Green CR, Poole-Wilson PA, Severs NJ. Reduced content of connexin43 gap junctions in ventricular myocardium from hypertrophied and ischemic human hearts. Circulation 1993;88:864-875. (Pubitemid 23264001)
35. Furukawa T, Kurokawa J. Potassium channel remodeling in cardiac hypertrophy. J Mol Cell Cardiol 2006;41:753-761. (Pubitemid 44635566)
36. Zitron E, Gunth M, Scherer D, Kiesecker C, Kulzer M, Bloehs R et al. Kir2.x inward rectifier potassium channels are differentially regulated by adrenergic alpha1A receptors. J Mol Cell Cardiol 2008;44:84-94.
37. Zhang TT, Takimoto K, Stewart AF, Zhu C, Levitan ES. Independent regulation of cardiac Kv4.3 potassium channel expression by angiotensin II and phenylephrine. Circ Res 2001;88:476-482. (Pubitemid 32240910)
38. Hoppe UC, Marban E, Johns DC. Molecular dissection of cardiac repolarization by in vivo Kv4.3 gene transfer. J Clin Invest 2000;105:1077-1084. (Pubitemid 30217692)